Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Polymeric nanoparticles show promise for treating skin diseases.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Both VEPA and ML-Y1 treatments are not effective enough for elderly non-Hodgkin's lymphoma patients.

Beer yeast vesicles may improve hair follicle health.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

VYC-12L effectively improves skin smoothness, reduces fine lines, and boosts hydration.

REVIVV® serum improves hair growth and reduces shedding in androgenetic alopecia.

Yeast-derived vesicles can improve hair follicle health and promote hair growth.

Provenge extends prostate cancer survival by about 4 months.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

VYC-15L is a safe and effective lip filler that lasts up to a year.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

Yeast extract helps treat hair loss and activates stem cells.

The protein ER71/ETV2 helps regrow hair after chemotherapy by improving the growth of new blood vessels.

EV-based drug delivery shows promise but faces challenges in standardization and scalability.

Medical Hair Restoration added a non-surgical hair therapy program to help people with early hair loss.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Injecting 2 ml of TEEV every 4 weeks is better because it has the same benefits but fewer side effects.

Entospletinib effectively prevents eye and skin GVHD in mice.